United Therapeutics Corporation (UTHR)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 336.37 |
| Open | 336.40 |
| Bid | 337.29 x 100 |
| Ask | 338.85 x 100 |
| Day's range | 336.32 - 340.44 |
| 52-week range | 208.62 - 343.98 |
| Volume | |
| Avg. volume | 563,290 |
| Market cap | 15.006B |
| Beta (5Y monthly) | 0.56 |
| PE ratio (TTM) | 16.02 |
| EPS (TTM) | 21.11 |
| Earnings date | 31 Jul 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 332.35 |
ZacksImplied Volatility Surging for United Therapeutics (UTHR) Stock Options
Investors need to pay close attention to United Therapeutics (UTHR) stock based on the movements in the options market lately.
ZacksWill PTC Therapeutics (PTCT) Report Negative Q2 Earnings? What You Should Know
PTC Therapeutics (PTCT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Business Wire
United Therapeutics Corporation to Report Second Quarter 2024 Financial Results Before the Market Opens on Wednesday, July 31, 2024
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., July 24, 2024--United Therapeutics Corporation (Nasdaq: UTHR), announced today that it will report its second quarter 2024 financial results before the market opens on Wednesday, July 31, 2024. A press release detailing the quarterly results will be issued that day at approximately 6:30 a.m. Eastern Time.
© 2024 Yahoo. All rights reserved.